Skip to main content
. 2021 Feb 15;10:565384. doi: 10.3389/fonc.2020.565384

Table 2.

Clinical response to apatinib and oral etoposide therapy.

Treatment efficacy Total Apatinib 500mg (n=16) Apatinib 425mg (n=15)
n (%) n (%) n (%)
Partial response 11 (35.5) 7 (43.8) 4 (26.7)
Stable disease 16 (51.6) 8 (50.0) 8 (53.3)
Disease progression 4 (12.9) 1 (6.3) 3 (20.0)
Overall response 11 (35.5) 7 (43.8) 4 (26.7)
Disease control 27 (87.1) 15 (93.8) 12 (80.0)
median PFS(m) 6.9 (6.0-7.9) 6.6 (1.4-11.7) 6.9 (5.3-8.6)